| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $12,875,524 ) (Continued on the next page) |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24TR004432 | Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | 003 | 3 | NIH | 1/16/2026 | $326,759 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08AI185260 | A Translational Bioinformatics Approach for Phenotyping and Genetic Risk of Severe Cutaneous Adverse Drug Reactions | 000 | 2 | NIH | 12/31/2025 | $186,332 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 1/13/2026 | $766,423 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK141801 | Liver and kidney responses to bilirubin as a nuclear receptor hormone | 000 | 2 | NIH | 12/10/2025 | $380,625 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA289528 | Molecular Mediators of Cell-free DNA biogenesis | 000 | 2 | NIH | 12/11/2025 | $603,132 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS141191 | Cerebrospinal fluid dynamics in Huntington's disease | 000 | 2 | NIH | 1/14/2026 | $558,967 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K25AG076864 | Development and Application of T1rho Dispersion Imaging of Aging Muscle | 000 | 4 | NIH | 1/15/2026 | $75,600 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 001 | 3 | NIH | 12/26/2025 | $120,128 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 001 | 1 | NIH | 12/19/2025 | $2,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 3 | NIH | 12/29/2025 | $616,459 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 001 | 1 | NIH | 1/9/2026 | $0 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $17,925 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131104 | Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular disease | 000 | 5 | NIH | 12/23/2025 | $490,258 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $56,277 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $80,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08EY032620 | Mechanisms of Photoreceptor Contribution to Retinal Inflammation in Diabetic Retinopathy | 000 | 5 | NIH | 1/9/2026 | $207,847 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI172064 | Regional Prospective Observational Research in Tuberculosis (RePORT) – Brazil Network | 000 | 4 | NIH | 1/9/2026 | $527,252 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 000 | 3 | NIH | 12/18/2025 | $181,255 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 21 | NIH | 12/9/2025 | $1,385,340 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI180038 | Human M Cells Require Coronin 1a | 000 | 3 | NIH | 12/31/2025 | $706,382 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 000 | 1 | NIH | 12/30/2025 | $734,957 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131070 | The Origins of Human Anti-Insulin B Lymphocytes in Type 1 Diabetes | 000 | 5 | NIH | 1/15/2026 | $421,441 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 001 | 3 | NIH | 1/12/2026 | $93,723 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131529 | Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral Therapy | 000 | 5 | NIH | 1/16/2026 | $856,050 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI172064 | Regional Prospective Observational Research in Tuberculosis (RePORT) – Brazil Network | 001 | 4 | NIH | 1/13/2026 | $472,748 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK132669 | Arginine regulation of alpha cell proliferation and function | 000 | 5 | NIH | 1/16/2026 | $412,210 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK135950 | in vivo MR characterization of pathological changes in liver microstructures | 000 | 3 | NIH | 1/16/2026 | $387,557 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI093234 | Statistical Methods for Ordinal Variables in HIV/AIDS Studies | 000 | 12 | NIH | 1/7/2026 | $580,364 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 00 | 4 | CDC | 1/5/2026 | $450,000 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24TR004432 | Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | 001 | 3 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24TR004432 | Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | 002 | 3 | NIH | 1/15/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K99LM014429 | Development and implementation of statistical machine learning methods to shorten rare disease odysseys | 000 | 2 | NIH | 1/19/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | 90DDUC0153 | Vanderbilt Kennedy Center for Excellence in Developmental Disabilities | 01 | 1 | ACL | 12/28/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL155207 | Biomarkers of ischemic brain injury in adults with sickle cell disease | 000 | 4 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 00 | 4 | CDC | 1/5/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01HG013776 | Vanderbilt Genomic Learning Health System Clinical Site | 000 | 2 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HL151871 | The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK126721 | The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study | 000 | 5 | NIH | 12/30/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI077505 | Pharmacogenomics of HIV Therapy | 000 | 16 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NU3HCK000006 | Enhanced Detection of Resistance, Antibiotic Stewardship and infection control, and Genome sequencing NETwork for AMR containment (DRAGNET) | 02 | 5 | CDC | 1/12/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NU3HCK000006 | Enhanced Detection of Resistance, Antibiotic Stewardship and infection control, and Genome sequencing NETwork for AMR containment (DRAGNET) | 02 | 5 | CDC | 1/12/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NU3HCK000006 | Enhanced Detection of Resistance, Antibiotic Stewardship and infection control, and Genome sequencing NETwork for AMR containment (DRAGNET) | 02 | 5 | CDC | 1/12/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK105550 | Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease | 002 | 13 | NIH | 1/22/2026 | $37,454 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK137997 | Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK139322 | Optimizing Stage 2 T1DM Management: Assessing the Impact of GLP-1Ra on Metabolic Outcomes in Patients Receiving Teplizumab | 000 | 2 | NIH | 12/2/2025 | $0 |
|
